FFA
OM icon

Farther Finance Advisors’s Outset Medical OM Stock Holding History

Farther Finance Advisors’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$357 Buy
93
+67
+258% +$275 ﹤0.01% 5342
2025
Q4 		$96 Buy
+26
New +$223 ﹤0.01% 5303
2024
Q3 		– Sell
-2
Closed -$114 – 4086
2024
Q2 		$114 Buy
+2
New +$98 ﹤0.01% 3585
2024
Q1 		– Sell
-7
Closed -$541 – 3686
2023
Q4 		$541 Buy
+7
New +$570 ﹤0.01% 2949

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Farther Finance Advisors's OM Position: Q1 2026 in Review

Farther Finance Advisors increased its Outset Medical (OM) stake by 258% in Q1 2026, buying an estimated $275 and bringing the position to 93 shares worth $357. The position accounts for ﹤0.01% of the portfolio, ranked #5342.

Farther Finance Advisors first reported a position in OM in Q4 2023 and has held it in 4 quarters since. The position peaked at $541 in Q4 2023. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • Farther Finance Advisors held 93 shares of Outset Medical worth $357 as of Q1 2026.
  • Farther Finance Advisors bought 67 Outset Medical shares in Q1 2026, an estimated $275.
  • Outset Medical made up ﹤0.01% of Farther Finance Advisors's portfolio in Q1 2026, its #5342 holding.
  • Farther Finance Advisors first reported a position in Outset Medical in Q4 2023 and has held it in 4 quarters since.
  • Farther Finance Advisors's Outset Medical position peaked at $541 in Q4 2023.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Farther Finance Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.